Phase 3Completed

Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

A Multicenter, Randomized, Double-Blind, Parallel Arm, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe 10 mg When Added to Atorvastatin 10 mg Versus Titration to Atorvastatin 20 mg and to 40 mg in Elderly Patients With Hypercholesterolemia at High Risk for CHD

Sponsor
Organon and Co (Industry)
Enrollment
1,053 enrolled
Conditions
Hypercholesterolemia
Interventions
ezetimibe and atorvastatin; atorvastatin; Placebo (unspecified)
Ages
older adults
Registry
NCT00418834

Full record on ClinicalTrials.gov

From the registry

A 12 week clinical trial in patients 65 years of age and older with hypercholesterolemia at high risk for coronary heart disease to study the effects of atorvastatin and ezetimibe given in combination and two higher doses of atorvastatin on lipid lowering.

Primary outcomes

  • Percent Change From Baseline in LDL-C at Week 6

History

  1. Last registry update

  2. Results first posted

  3. Primary completion

  4. Started

  5. Registered